ANI Pharmaceuticals, Inc. (ANIP)HEAD OF RARE DISEASE sold ~$375K
Christopher Mutz, HEAD OF RARE DISEASE at ANI Pharmaceuticals, Inc., sold ~$375K of ANI Pharmaceuticals, Inc. shares.
- ~$375K
- Approx. value · 6,500 sh @ $57.70
- 77K
- Holds after · shares reported
- Traded
- Nov 15, 2024
- Filed
- Nov 18, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 14, 2024InsiderOfficer sold ~$14K of ANIP shares in the open market
- Nov 13, 2024InsiderOfficer sold ~$15K of ANIP shares in the open market
- Nov 15, 2024 · this disclosureInsiderOfficer sold ~$375K of ANIP shares in the open market
What came next
- Nov 26, 2024Insider · 1 personInsiders: 2 sales (~$1.9M)
- Dec 11, 2024InsiderOfficer sold ~$60K of ANIP shares in the open market
- Dec 13, 2024InsiderOfficer sold ~$14K of ANIP shares in the open market
- Dec 17, 2024InsiderCFO sold ~$418K of ANIP shares in the open market
- Jan 13, 2025InsiderOfficer sold ~$22K of ANIP shares in the open market
- Feb 13, 2025InsiderOfficer sold ~$24K of ANIP shares in the open market
- Feb 21, 2025InsiderOfficer sold ~$60K of ANIP shares in the open market
- Mar 5, 2025Insider · 1 personInsiders: 2 sales (~$323K)
- Mar 7, 2025InsiderOfficer sold ~$61K of ANIP shares in the open market
- Mar 13, 2025InsiderOfficer sold ~$25K of ANIP shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for ANI Pharmaceuticals, Inc.
For ANI Pharmaceuticals, Inc., OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANIP page.
Other recent filings by Christopher Mutz, HEAD OF RARE DISEASE
The full history of Christopher Mutz, HEAD OF RARE DISEASE is on the profile page.
How this filing works
Other disclosures at ANI Pharmaceuticals, Inc.
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 14, 2026
- SEC Form 13F-HRMay 13, 2026
Everything OQRO holds on this company is on its ANIP page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data